GLP-1 on Non-ST-Segment Elevation Myocardial Infarction

• Status: Unknown status
• Trial end date: 2016-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators planned to evaluate the effects of liraglutide on left ventricular function in patients with non-ST-segment elevation myocardial infarction (NSTEMI).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chinese PLA General Hospital
• Treatments: Glucagon; Glucagon-Like Peptide 1; Liraglutide

Criteria

Inclusion Criteria:

non-ST-segment elevation myocardial infarction (NSTEMI )

Exclusion Criteria:

1. unconscious at presentation

2. had ST-segment elevation acute myocardial infarction

3. NSTEMI requiring emergency percutaneous coronary angiography

4. valvular heart disease

5. cardiogenic shock

6. hypoglycaemia

7. diabetic ketoacidosis

8. had a history of myocardial infarction

9. stent implantation

10. renal insufficiency

11. had previously undergone coronary artery bypass surgery.